Accurate transcriptome assembly by Nanopore RNA sequencing reveals novel functional transcripts in hepatocellular carcinoma

The long reads of Nanopore sequencing permit accurate transcript assembly and ease in discovering novel transcripts with potentially important functions in cancers. The wide adoption of Nanopore sequencing for transcript quantification, however, is largely limited by high costs. To address this issu...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cancer science 2021-09, Vol.112 (9), p.3555-3568
Hauptverfasser: Fang, Yuanchang, Chen, Geng, Chen, Feng, Hu, En, Dong, Xiuqing, Li, Zhenli, He, Lei, Sun, Yupeng, Qiu, Liman, Xu, Haipo, Cai, Zhixiong, Liu, Xiaolong
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 3568
container_issue 9
container_start_page 3555
container_title Cancer science
container_volume 112
creator Fang, Yuanchang
Chen, Geng
Chen, Feng
Hu, En
Dong, Xiuqing
Li, Zhenli
He, Lei
Sun, Yupeng
Qiu, Liman
Xu, Haipo
Cai, Zhixiong
Liu, Xiaolong
description The long reads of Nanopore sequencing permit accurate transcript assembly and ease in discovering novel transcripts with potentially important functions in cancers. The wide adoption of Nanopore sequencing for transcript quantification, however, is largely limited by high costs. To address this issue, we developed a bioinformatics software, NovelQuant, that can specifically quantify long‐read‐assembled novel transcripts with short‐read sequencing data. Nanopore Direct RNA Sequencing was carried out on three hepatocellular carcinoma (HCC) patients’ tumor, matched portal vein tumor thrombus, and peritumor to reconstruct the HCC transcriptome. Then, based on the reconstructed transcriptome, NovelQuant was applied on Illumina RNA sequencing data of 59 HCC patients’ tumor and paired peritumor to quantify novel transcripts. Our further analysis revealed 361 novel transcripts dysregulated in HCC and that 101 of them were significantly associated with prognosis. There were 19 novel prognostic transcripts predicted to be long noncoding RNAs (lncRNAs), and some of them had regulatory targets that were reported to be associated with HCC. Additionally, 42 novel prognostic transcripts were predicted to be protein‐coding mRNAs, and many of them could be involved in xenobiotic metabolism. Moreover, the tumor‐suppressive roles of two representative novel prognostic transcripts, CDO1‐novel (lncRNA) and CYP2A6‐novel (protein‐coding mRNA), were further functionally validated during HCC progression. Overall, the current study shows a possibility of combining long‐ and short‐read sequencing to explore functionally important novel transcripts in HCC with accuracy and cost‐efficiency, which expands the pool of molecular biomarkers that could enhance our understanding of the molecular mechanisms of HCC. We used Nanopore RNA sequencing to discover novel transcripts in hepatocellular carcinoma (HCC), and developed NovelQuant to specifically quantify novel transcripts. Many of these novel transcripts were further found to be predictive of prognosis and have functional roles in HCC.
doi_str_mv 10.1111/cas.15058
format Article
fullrecord <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8409408</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A710748713</galeid><sourcerecordid>A710748713</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5118-a2f5de4b83861a96e58fae91a4058c1673f468ccdc69b87cd1b0171f60dbb5133</originalsourceid><addsrcrecordid>eNp1kl2P1CAUhhujcdfVC_8BiTd60VkolI8bk2biV7JZEz-uCaWns2xaqNCOmfjnpTMbdY3CBQSe9-W85BTFc4I3JI9La9KG1LiWD4pzQpkqBcb84XEvSoVpdVY8SekWY8qZYo-LM8qquqaKnxc_GmuXaGZAczQ-2eimOYyATEowtsMBtQd0bXyYQgT06bpBCb4t4K3zOxRhD2ZIyIc9DKhfvJ1d8Gb4wyoh59ENTGYOFoZhGUxE1sQsD6N5Wjzqsx6e3a0Xxde3b75s35dXH9992DZXpa0JkaWp-roD1koqOTGKQy17A4oYlhNbwgXtGZfWdparVgrbkRYTQXqOu7atCaUXxeuT77S0I3QWfC5w0FN0o4kHHYzT92-8u9G7sNeSYcWwzAYv7wxiyOnTrEeX1jzGQ1iSzp9JKoIrtaIv_kJvwxLzp6wUF0pIWuPf1M4MoJ3vQ37Xrqa6EQQLJsWx7s0_qDw7GJ0NHnqXz-8JXp0ENoaUIvS_MhKs107RuVP0sVMye3liv2eTw_9BvW0-nxQ_Af0cv9U</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2567978350</pqid></control><display><type>article</type><title>Accurate transcriptome assembly by Nanopore RNA sequencing reveals novel functional transcripts in hepatocellular carcinoma</title><source>DOAJ Directory of Open Access Journals</source><source>Access via Wiley Online Library</source><source>Wiley Online Library (Open Access Collection)</source><source>PubMed Central</source><creator>Fang, Yuanchang ; Chen, Geng ; Chen, Feng ; Hu, En ; Dong, Xiuqing ; Li, Zhenli ; He, Lei ; Sun, Yupeng ; Qiu, Liman ; Xu, Haipo ; Cai, Zhixiong ; Liu, Xiaolong</creator><creatorcontrib>Fang, Yuanchang ; Chen, Geng ; Chen, Feng ; Hu, En ; Dong, Xiuqing ; Li, Zhenli ; He, Lei ; Sun, Yupeng ; Qiu, Liman ; Xu, Haipo ; Cai, Zhixiong ; Liu, Xiaolong</creatorcontrib><description>The long reads of Nanopore sequencing permit accurate transcript assembly and ease in discovering novel transcripts with potentially important functions in cancers. The wide adoption of Nanopore sequencing for transcript quantification, however, is largely limited by high costs. To address this issue, we developed a bioinformatics software, NovelQuant, that can specifically quantify long‐read‐assembled novel transcripts with short‐read sequencing data. Nanopore Direct RNA Sequencing was carried out on three hepatocellular carcinoma (HCC) patients’ tumor, matched portal vein tumor thrombus, and peritumor to reconstruct the HCC transcriptome. Then, based on the reconstructed transcriptome, NovelQuant was applied on Illumina RNA sequencing data of 59 HCC patients’ tumor and paired peritumor to quantify novel transcripts. Our further analysis revealed 361 novel transcripts dysregulated in HCC and that 101 of them were significantly associated with prognosis. There were 19 novel prognostic transcripts predicted to be long noncoding RNAs (lncRNAs), and some of them had regulatory targets that were reported to be associated with HCC. Additionally, 42 novel prognostic transcripts were predicted to be protein‐coding mRNAs, and many of them could be involved in xenobiotic metabolism. Moreover, the tumor‐suppressive roles of two representative novel prognostic transcripts, CDO1‐novel (lncRNA) and CYP2A6‐novel (protein‐coding mRNA), were further functionally validated during HCC progression. Overall, the current study shows a possibility of combining long‐ and short‐read sequencing to explore functionally important novel transcripts in HCC with accuracy and cost‐efficiency, which expands the pool of molecular biomarkers that could enhance our understanding of the molecular mechanisms of HCC. We used Nanopore RNA sequencing to discover novel transcripts in hepatocellular carcinoma (HCC), and developed NovelQuant to specifically quantify novel transcripts. Many of these novel transcripts were further found to be predictive of prognosis and have functional roles in HCC.</description><identifier>ISSN: 1347-9032</identifier><identifier>EISSN: 1349-7006</identifier><identifier>DOI: 10.1111/cas.15058</identifier><identifier>PMID: 34255396</identifier><language>eng</language><publisher>Tokyo: John Wiley &amp; Sons, Inc</publisher><subject>Analysis ; Annotations ; Bioinformatics ; Blood clot ; CDO1 ; CYP2A6 ; DNA sequencing ; Genes ; Hepatocellular carcinoma ; Hepatoma ; Liver cancer ; Medical prognosis ; Messenger RNA ; Molecular modelling ; Nanopore sequencing ; novel transcript ; Nucleotide sequencing ; Original ; Patients ; Portal vein ; Proteins ; RNA sequencing ; Thrombosis ; Transcription ; Transcriptomes</subject><ispartof>Cancer science, 2021-09, Vol.112 (9), p.3555-3568</ispartof><rights>2021 The Authors. published by John Wiley &amp; Sons Australia, Ltd on behalf of Japanese Cancer Association.</rights><rights>COPYRIGHT 2021 John Wiley &amp; Sons, Inc.</rights><rights>2021. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5118-a2f5de4b83861a96e58fae91a4058c1673f468ccdc69b87cd1b0171f60dbb5133</citedby><cites>FETCH-LOGICAL-c5118-a2f5de4b83861a96e58fae91a4058c1673f468ccdc69b87cd1b0171f60dbb5133</cites><orcidid>0000-0002-3096-4981</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8409408/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8409408/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,864,885,1417,11562,27924,27925,45574,45575,46052,46476,53791,53793</link.rule.ids></links><search><creatorcontrib>Fang, Yuanchang</creatorcontrib><creatorcontrib>Chen, Geng</creatorcontrib><creatorcontrib>Chen, Feng</creatorcontrib><creatorcontrib>Hu, En</creatorcontrib><creatorcontrib>Dong, Xiuqing</creatorcontrib><creatorcontrib>Li, Zhenli</creatorcontrib><creatorcontrib>He, Lei</creatorcontrib><creatorcontrib>Sun, Yupeng</creatorcontrib><creatorcontrib>Qiu, Liman</creatorcontrib><creatorcontrib>Xu, Haipo</creatorcontrib><creatorcontrib>Cai, Zhixiong</creatorcontrib><creatorcontrib>Liu, Xiaolong</creatorcontrib><title>Accurate transcriptome assembly by Nanopore RNA sequencing reveals novel functional transcripts in hepatocellular carcinoma</title><title>Cancer science</title><description>The long reads of Nanopore sequencing permit accurate transcript assembly and ease in discovering novel transcripts with potentially important functions in cancers. The wide adoption of Nanopore sequencing for transcript quantification, however, is largely limited by high costs. To address this issue, we developed a bioinformatics software, NovelQuant, that can specifically quantify long‐read‐assembled novel transcripts with short‐read sequencing data. Nanopore Direct RNA Sequencing was carried out on three hepatocellular carcinoma (HCC) patients’ tumor, matched portal vein tumor thrombus, and peritumor to reconstruct the HCC transcriptome. Then, based on the reconstructed transcriptome, NovelQuant was applied on Illumina RNA sequencing data of 59 HCC patients’ tumor and paired peritumor to quantify novel transcripts. Our further analysis revealed 361 novel transcripts dysregulated in HCC and that 101 of them were significantly associated with prognosis. There were 19 novel prognostic transcripts predicted to be long noncoding RNAs (lncRNAs), and some of them had regulatory targets that were reported to be associated with HCC. Additionally, 42 novel prognostic transcripts were predicted to be protein‐coding mRNAs, and many of them could be involved in xenobiotic metabolism. Moreover, the tumor‐suppressive roles of two representative novel prognostic transcripts, CDO1‐novel (lncRNA) and CYP2A6‐novel (protein‐coding mRNA), were further functionally validated during HCC progression. Overall, the current study shows a possibility of combining long‐ and short‐read sequencing to explore functionally important novel transcripts in HCC with accuracy and cost‐efficiency, which expands the pool of molecular biomarkers that could enhance our understanding of the molecular mechanisms of HCC. We used Nanopore RNA sequencing to discover novel transcripts in hepatocellular carcinoma (HCC), and developed NovelQuant to specifically quantify novel transcripts. Many of these novel transcripts were further found to be predictive of prognosis and have functional roles in HCC.</description><subject>Analysis</subject><subject>Annotations</subject><subject>Bioinformatics</subject><subject>Blood clot</subject><subject>CDO1</subject><subject>CYP2A6</subject><subject>DNA sequencing</subject><subject>Genes</subject><subject>Hepatocellular carcinoma</subject><subject>Hepatoma</subject><subject>Liver cancer</subject><subject>Medical prognosis</subject><subject>Messenger RNA</subject><subject>Molecular modelling</subject><subject>Nanopore sequencing</subject><subject>novel transcript</subject><subject>Nucleotide sequencing</subject><subject>Original</subject><subject>Patients</subject><subject>Portal vein</subject><subject>Proteins</subject><subject>RNA sequencing</subject><subject>Thrombosis</subject><subject>Transcription</subject><subject>Transcriptomes</subject><issn>1347-9032</issn><issn>1349-7006</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>24P</sourceid><sourceid>WIN</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNp1kl2P1CAUhhujcdfVC_8BiTd60VkolI8bk2biV7JZEz-uCaWns2xaqNCOmfjnpTMbdY3CBQSe9-W85BTFc4I3JI9La9KG1LiWD4pzQpkqBcb84XEvSoVpdVY8SekWY8qZYo-LM8qquqaKnxc_GmuXaGZAczQ-2eimOYyATEowtsMBtQd0bXyYQgT06bpBCb4t4K3zOxRhD2ZIyIc9DKhfvJ1d8Gb4wyoh59ENTGYOFoZhGUxE1sQsD6N5Wjzqsx6e3a0Xxde3b75s35dXH9992DZXpa0JkaWp-roD1koqOTGKQy17A4oYlhNbwgXtGZfWdparVgrbkRYTQXqOu7atCaUXxeuT77S0I3QWfC5w0FN0o4kHHYzT92-8u9G7sNeSYcWwzAYv7wxiyOnTrEeX1jzGQ1iSzp9JKoIrtaIv_kJvwxLzp6wUF0pIWuPf1M4MoJ3vQ37Xrqa6EQQLJsWx7s0_qDw7GJ0NHnqXz-8JXp0ENoaUIvS_MhKs107RuVP0sVMye3liv2eTw_9BvW0-nxQ_Af0cv9U</recordid><startdate>202109</startdate><enddate>202109</enddate><creator>Fang, Yuanchang</creator><creator>Chen, Geng</creator><creator>Chen, Feng</creator><creator>Hu, En</creator><creator>Dong, Xiuqing</creator><creator>Li, Zhenli</creator><creator>He, Lei</creator><creator>Sun, Yupeng</creator><creator>Qiu, Liman</creator><creator>Xu, Haipo</creator><creator>Cai, Zhixiong</creator><creator>Liu, Xiaolong</creator><general>John Wiley &amp; Sons, Inc</general><general>John Wiley and Sons Inc</general><scope>24P</scope><scope>WIN</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>8FE</scope><scope>8FH</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>LK8</scope><scope>M7P</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-3096-4981</orcidid></search><sort><creationdate>202109</creationdate><title>Accurate transcriptome assembly by Nanopore RNA sequencing reveals novel functional transcripts in hepatocellular carcinoma</title><author>Fang, Yuanchang ; Chen, Geng ; Chen, Feng ; Hu, En ; Dong, Xiuqing ; Li, Zhenli ; He, Lei ; Sun, Yupeng ; Qiu, Liman ; Xu, Haipo ; Cai, Zhixiong ; Liu, Xiaolong</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5118-a2f5de4b83861a96e58fae91a4058c1673f468ccdc69b87cd1b0171f60dbb5133</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Analysis</topic><topic>Annotations</topic><topic>Bioinformatics</topic><topic>Blood clot</topic><topic>CDO1</topic><topic>CYP2A6</topic><topic>DNA sequencing</topic><topic>Genes</topic><topic>Hepatocellular carcinoma</topic><topic>Hepatoma</topic><topic>Liver cancer</topic><topic>Medical prognosis</topic><topic>Messenger RNA</topic><topic>Molecular modelling</topic><topic>Nanopore sequencing</topic><topic>novel transcript</topic><topic>Nucleotide sequencing</topic><topic>Original</topic><topic>Patients</topic><topic>Portal vein</topic><topic>Proteins</topic><topic>RNA sequencing</topic><topic>Thrombosis</topic><topic>Transcription</topic><topic>Transcriptomes</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Fang, Yuanchang</creatorcontrib><creatorcontrib>Chen, Geng</creatorcontrib><creatorcontrib>Chen, Feng</creatorcontrib><creatorcontrib>Hu, En</creatorcontrib><creatorcontrib>Dong, Xiuqing</creatorcontrib><creatorcontrib>Li, Zhenli</creatorcontrib><creatorcontrib>He, Lei</creatorcontrib><creatorcontrib>Sun, Yupeng</creatorcontrib><creatorcontrib>Qiu, Liman</creatorcontrib><creatorcontrib>Xu, Haipo</creatorcontrib><creatorcontrib>Cai, Zhixiong</creatorcontrib><creatorcontrib>Liu, Xiaolong</creatorcontrib><collection>Wiley Online Library (Open Access Collection)</collection><collection>Wiley Online Library (Open Access Collection)</collection><collection>CrossRef</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Biological Science Collection</collection><collection>Biological Science Database</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Cancer science</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Fang, Yuanchang</au><au>Chen, Geng</au><au>Chen, Feng</au><au>Hu, En</au><au>Dong, Xiuqing</au><au>Li, Zhenli</au><au>He, Lei</au><au>Sun, Yupeng</au><au>Qiu, Liman</au><au>Xu, Haipo</au><au>Cai, Zhixiong</au><au>Liu, Xiaolong</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Accurate transcriptome assembly by Nanopore RNA sequencing reveals novel functional transcripts in hepatocellular carcinoma</atitle><jtitle>Cancer science</jtitle><date>2021-09</date><risdate>2021</risdate><volume>112</volume><issue>9</issue><spage>3555</spage><epage>3568</epage><pages>3555-3568</pages><issn>1347-9032</issn><eissn>1349-7006</eissn><abstract>The long reads of Nanopore sequencing permit accurate transcript assembly and ease in discovering novel transcripts with potentially important functions in cancers. The wide adoption of Nanopore sequencing for transcript quantification, however, is largely limited by high costs. To address this issue, we developed a bioinformatics software, NovelQuant, that can specifically quantify long‐read‐assembled novel transcripts with short‐read sequencing data. Nanopore Direct RNA Sequencing was carried out on three hepatocellular carcinoma (HCC) patients’ tumor, matched portal vein tumor thrombus, and peritumor to reconstruct the HCC transcriptome. Then, based on the reconstructed transcriptome, NovelQuant was applied on Illumina RNA sequencing data of 59 HCC patients’ tumor and paired peritumor to quantify novel transcripts. Our further analysis revealed 361 novel transcripts dysregulated in HCC and that 101 of them were significantly associated with prognosis. There were 19 novel prognostic transcripts predicted to be long noncoding RNAs (lncRNAs), and some of them had regulatory targets that were reported to be associated with HCC. Additionally, 42 novel prognostic transcripts were predicted to be protein‐coding mRNAs, and many of them could be involved in xenobiotic metabolism. Moreover, the tumor‐suppressive roles of two representative novel prognostic transcripts, CDO1‐novel (lncRNA) and CYP2A6‐novel (protein‐coding mRNA), were further functionally validated during HCC progression. Overall, the current study shows a possibility of combining long‐ and short‐read sequencing to explore functionally important novel transcripts in HCC with accuracy and cost‐efficiency, which expands the pool of molecular biomarkers that could enhance our understanding of the molecular mechanisms of HCC. We used Nanopore RNA sequencing to discover novel transcripts in hepatocellular carcinoma (HCC), and developed NovelQuant to specifically quantify novel transcripts. Many of these novel transcripts were further found to be predictive of prognosis and have functional roles in HCC.</abstract><cop>Tokyo</cop><pub>John Wiley &amp; Sons, Inc</pub><pmid>34255396</pmid><doi>10.1111/cas.15058</doi><tpages>14</tpages><orcidid>https://orcid.org/0000-0002-3096-4981</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1347-9032
ispartof Cancer science, 2021-09, Vol.112 (9), p.3555-3568
issn 1347-9032
1349-7006
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8409408
source DOAJ Directory of Open Access Journals; Access via Wiley Online Library; Wiley Online Library (Open Access Collection); PubMed Central
subjects Analysis
Annotations
Bioinformatics
Blood clot
CDO1
CYP2A6
DNA sequencing
Genes
Hepatocellular carcinoma
Hepatoma
Liver cancer
Medical prognosis
Messenger RNA
Molecular modelling
Nanopore sequencing
novel transcript
Nucleotide sequencing
Original
Patients
Portal vein
Proteins
RNA sequencing
Thrombosis
Transcription
Transcriptomes
title Accurate transcriptome assembly by Nanopore RNA sequencing reveals novel functional transcripts in hepatocellular carcinoma
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T02%3A07%3A51IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Accurate%20transcriptome%20assembly%20by%20Nanopore%20RNA%20sequencing%20reveals%20novel%20functional%20transcripts%20in%20hepatocellular%20carcinoma&rft.jtitle=Cancer%20science&rft.au=Fang,%20Yuanchang&rft.date=2021-09&rft.volume=112&rft.issue=9&rft.spage=3555&rft.epage=3568&rft.pages=3555-3568&rft.issn=1347-9032&rft.eissn=1349-7006&rft_id=info:doi/10.1111/cas.15058&rft_dat=%3Cgale_pubme%3EA710748713%3C/gale_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2567978350&rft_id=info:pmid/34255396&rft_galeid=A710748713&rfr_iscdi=true